Selected research
Industry Growth & Trends
Global Lung Tumor Ablation Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Lung Tumor Ablation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Lung Tumor Ablation is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Lung Tumor Ablation is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Lung Tumor Ablation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Lung Tumor Ablation market include Angiodynamics, Auris Health, Intuitive Surgica, Nanjing MICRO-TECH, Smith and Nephew, VISON Medical, Olympus, Boston Scientific and Broncus, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Lung Tumor Ablation market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Lung Tumor Ablation market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Lung Tumor Ablation market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Lung Tumor Ablation.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Lung Tumor Ablation market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Lung Tumor Ablation Market by Company
Angiodynamics
Auris Health
Intuitive Surgica
Nanjing MICRO-TECH
Smith and Nephew
VISON Medical
Olympus
Boston Scientific
Broncus
LungCare
Medtronic
TIPC
Lung Tumor Ablation Segment by Type
Microwave Ablation (MWA)
Radiofrequency Ablation (RFA)
Cold Ablation
Others
Lung Tumor Ablation Segment by Application
Hospitals
Ambulatory Surgical Centers
Lung Tumor Ablation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lung Tumor Ablation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lung Tumor Ablation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lung Tumor Ablation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Lung Tumor Ablation companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Microwave Ablation (MWA)
- Radiofrequency Ablation (RFA)
- Cold Ablation
- Others
Applications
- Hospitals
- Ambulatory Surgical Centers
Companies covered
- Angiodynamics
- Auris Health
- Intuitive Surgica
- Nanjing MICRO-TECH
- Smith and Nephew
- VISON Medical
- Olympus
- Boston Scientific
- Broncus
- LungCare
- Medtronic
- TIPC
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Lung Tumor Ablation Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Lung Tumor Ablation Market Size by Region (2021-2032)
- 1.4.1 Global Lung Tumor Ablation Market Size by Region (2021-2026)
- 1.4.2 Global Lung Tumor Ablation Market Size by Region (2027-2032)
- 1.5 Key Regions Lung Tumor Ablation Market Size (2021-2032)
- 1.5.1 North America Lung Tumor Ablation Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Lung Tumor Ablation Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Lung Tumor Ablation Market Size Growth Rate (2021-2032)
- 1.5.4 South America Lung Tumor Ablation Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Lung Tumor Ablation Market Size Growth Rate (2021-2032)
2 Lung Tumor Ablation Market by Type
- 2.1 Type Introduction
- 2.1.1 Microwave Ablation (MWA)
- 2.1.2 Radiofrequency Ablation (RFA)
- 2.1.3 Cold Ablation
- 2.1.4 Others
- 2.2 Global Lung Tumor Ablation Market Size by Type
- 2.2.1 Global Lung Tumor Ablation Market Size Overview by Type (2021-2032)
- 2.2.2 Global Lung Tumor Ablation Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Lung Tumor Ablation Market Size Forecasted by Type (2027-2032)
- 2.3 Global Lung Tumor Ablation Market Size by Regions
- 2.3.1 North America Lung Tumor Ablation Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Lung Tumor Ablation Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Lung Tumor Ablation Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Lung Tumor Ablation Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Lung Tumor Ablation Market Size Breakdown by Type (2021-2026)
3 Lung Tumor Ablation Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospitals
- 3.1.2 Ambulatory Surgical Centers
- 3.2 Global Lung Tumor Ablation Market Size by Application
- 3.2.1 Global Lung Tumor Ablation Market Size Overview by Application (2021-2032)
- 3.2.2 Global Lung Tumor Ablation Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Lung Tumor Ablation Market Size Forecasted by Application (2027-2032)
- 3.3 Global Lung Tumor Ablation Market Size by Regions
- 3.3.1 North America Lung Tumor Ablation Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Lung Tumor Ablation Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Lung Tumor Ablation Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Lung Tumor Ablation Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Lung Tumor Ablation Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Lung Tumor Ablation Industry Trends
- 4.2 Lung Tumor Ablation Industry Drivers
- 4.3 Lung Tumor Ablation Industry Opportunities and Challenges
- 4.4 Lung Tumor Ablation Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Lung Tumor Ablation Revenue (2021-2026)
- 5.2 Global Lung Tumor Ablation Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Lung Tumor Ablation Key Company Headquarters & Area Served
- 5.4 Global Lung Tumor Ablation Company, Product Type & Application
- 5.5 Global Lung Tumor Ablation Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Lung Tumor Ablation Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Lung Tumor Ablation Players Market Share by Revenue in 2025
- 5.6.3 2025 Lung Tumor Ablation Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Angiodynamics
- 6.1.1 Angiodynamics Company Information
- 6.1.2 Angiodynamics Business Overview
- 6.1.3 Angiodynamics Lung Tumor Ablation Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Angiodynamics Lung Tumor Ablation Product Portfolio
- 6.1.5 Angiodynamics Recent Developments
- 6.2 Auris Health
- 6.2.1 Auris Health Company Information
- 6.2.2 Auris Health Business Overview
- 6.2.3 Auris Health Lung Tumor Ablation Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Auris Health Lung Tumor Ablation Product Portfolio
- 6.2.5 Auris Health Recent Developments
- 6.3 Intuitive Surgica
- 6.3.1 Intuitive Surgica Company Information
- 6.3.2 Intuitive Surgica Business Overview
- 6.3.3 Intuitive Surgica Lung Tumor Ablation Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Intuitive Surgica Lung Tumor Ablation Product Portfolio
- 6.3.5 Intuitive Surgica Recent Developments
- 6.4 Nanjing MICRO-TECH
- 6.4.1 Nanjing MICRO-TECH Company Information
- 6.4.2 Nanjing MICRO-TECH Business Overview
- 6.4.3 Nanjing MICRO-TECH Lung Tumor Ablation Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Nanjing MICRO-TECH Lung Tumor Ablation Product Portfolio
- 6.4.5 Nanjing MICRO-TECH Recent Developments
- 6.5 Smith and Nephew
- 6.5.1 Smith and Nephew Company Information
- 6.5.2 Smith and Nephew Business Overview
- 6.5.3 Smith and Nephew Lung Tumor Ablation Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Smith and Nephew Lung Tumor Ablation Product Portfolio
- 6.5.5 Smith and Nephew Recent Developments
- 6.6 VISON Medical
- 6.6.1 VISON Medical Company Information
- 6.6.2 VISON Medical Business Overview
- 6.6.3 VISON Medical Lung Tumor Ablation Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 VISON Medical Lung Tumor Ablation Product Portfolio
- 6.6.5 VISON Medical Recent Developments
- 6.7 Olympus
- 6.7.1 Olympus Company Information
- 6.7.2 Olympus Business Overview
- 6.7.3 Olympus Lung Tumor Ablation Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Olympus Lung Tumor Ablation Product Portfolio
- 6.7.5 Olympus Recent Developments
- 6.8 Boston Scientific
- 6.8.1 Boston Scientific Company Information
- 6.8.2 Boston Scientific Business Overview
- 6.8.3 Boston Scientific Lung Tumor Ablation Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Boston Scientific Lung Tumor Ablation Product Portfolio
- 6.8.5 Boston Scientific Recent Developments
- 6.9 Broncus
- 6.9.1 Broncus Company Information
- 6.9.2 Broncus Business Overview
- 6.9.3 Broncus Lung Tumor Ablation Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Broncus Lung Tumor Ablation Product Portfolio
- 6.9.5 Broncus Recent Developments
- 6.10 LungCare
- 6.10.1 LungCare Company Information
- 6.10.2 LungCare Business Overview
- 6.10.3 LungCare Lung Tumor Ablation Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 LungCare Lung Tumor Ablation Product Portfolio
- 6.10.5 LungCare Recent Developments
- 6.11 Medtronic
- 6.11.1 Medtronic Company Information
- 6.11.2 Medtronic Business Overview
- 6.11.3 Medtronic Lung Tumor Ablation Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Medtronic Lung Tumor Ablation Product Portfolio
- 6.11.5 Medtronic Recent Developments
- 6.12 TIPC
- 6.12.1 TIPC Company Information
- 6.12.2 TIPC Business Overview
- 6.12.3 TIPC Lung Tumor Ablation Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 TIPC Lung Tumor Ablation Product Portfolio
- 6.12.5 TIPC Recent Developments
7 North America
- 7.1 North America Lung Tumor Ablation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Lung Tumor Ablation Market Size by Country (2021-2026)
- 7.3 North America Lung Tumor Ablation Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Lung Tumor Ablation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Lung Tumor Ablation Market Size by Country (2021-2026)
- 8.3 Europe Lung Tumor Ablation Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Lung Tumor Ablation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Lung Tumor Ablation Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Lung Tumor Ablation Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Lung Tumor Ablation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Lung Tumor Ablation Market Size by Country (2021-2026)
- 10.3 South America Lung Tumor Ablation Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Lung Tumor Ablation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Lung Tumor Ablation Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Lung Tumor Ablation Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst